Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 1
2005 4
2006 3
2007 3
2008 4
2009 6
2010 4
2011 4
2012 2
2013 2
2014 3
2015 10
2016 7
2017 12
2018 13
2019 9
2020 20
2021 24
2022 29
2023 27
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Results by year

Filters applied: . Clear all
Page 1
Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer.
Smith MR, Hussain M, Saad F, Fizazi K, Sternberg CN, Crawford ED, Kopyltsov E, Park CH, Alekseev B, Montesa-Pino Á, Ye D, Parnis F, Cruz F, Tammela TLJ, Suzuki H, Utriainen T, Fu C, Uemura M, Méndez-Vidal MJ, Maughan BL, Joensuu H, Thiele S, Li R, Kuss I, Tombal B; ARASENS Trial Investigators. Smith MR, et al. N Engl J Med. 2022 Mar 24;386(12):1132-1142. doi: 10.1056/NEJMoa2119115. Epub 2022 Feb 17. N Engl J Med. 2022. PMID: 35179323 Free PMC article. Clinical Trial.
Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.
Smith MR, Saad F, Chowdhury S, Oudard S, Hadaschik BA, Graff JN, Olmos D, Mainwaring PN, Lee JY, Uemura H, Lopez-Gitlitz A, Trudel GC, Espina BM, Shu Y, Park YC, Rackoff WR, Yu MK, Small EJ; SPARTAN Investigators. Smith MR, et al. N Engl J Med. 2018 Apr 12;378(15):1408-1418. doi: 10.1056/NEJMoa1715546. Epub 2018 Feb 8. N Engl J Med. 2018. PMID: 29420164 Free article. Clinical Trial.
Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer: The VIABLE Phase 3 Randomized Clinical Trial.
Vogelzang NJ, Beer TM, Gerritsen W, Oudard S, Wiechno P, Kukielka-Budny B, Samal V, Hajek J, Feyerabend S, Khoo V, Stenzl A, Csöszi T, Filipovic Z, Goncalves F, Prokhorov A, Cheung E, Hussain A, Sousa N, Bahl A, Hussain S, Fricke H, Kadlecova P, Scheiner T, Korolkiewicz RP, Bartunkova J, Spisek R; VIABLE Investigators. Vogelzang NJ, et al. JAMA Oncol. 2022 Apr 1;8(4):546-552. doi: 10.1001/jamaoncol.2021.7298. JAMA Oncol. 2022. PMID: 35142815 Free PMC article. Clinical Trial.
COVID-19 and BCG: where's the challenge?
Mjaess G, Lilly E, Mansour R, Albisinni S, Nemr E, Aoun F, Roumeguere T. Mjaess G, et al. Among authors: roumeguere t. World J Urol. 2022 Mar;40(3):867-869. doi: 10.1007/s00345-020-03554-9. Epub 2021 Jan 2. World J Urol. 2022. PMID: 33386950 Free PMC article. No abstract available.
Antibody-Drug Conjugates in Prostate Cancer: Where Are we?
Mjaess G, Aoun F, Rassy E, Diamand R, Albisinni S, Roumeguère T. Mjaess G, et al. Among authors: roumeguere t. Clin Genitourin Cancer. 2023 Feb;21(1):171-174. doi: 10.1016/j.clgc.2022.07.009. Epub 2022 Jul 23. Clin Genitourin Cancer. 2023. PMID: 35999150 Review.
Sexual dysfunction due to pudendal neuralgia: a systematic review.
Aoun F, Alkassis M, Tayeh GA, Chebel JA, Semaan A, Sarkis J, Mansour R, Mjaess G, Albisinni S, Absil F, Bollens R, Roumeguère T. Aoun F, et al. Among authors: roumeguere t. Transl Androl Urol. 2021 Jun;10(6):2500-2511. doi: 10.21037/tau-21-13. Transl Androl Urol. 2021. PMID: 34295736 Free PMC article. Review.
Oxidative stress and prostatic diseases.
Roumeguère T, Sfeir J, El Rassy E, Albisinni S, Van Antwerpen P, Boudjeltia KZ, Farès N, Kattan J, Aoun F. Roumeguère T, et al. Mol Clin Oncol. 2017 Nov;7(5):723-728. doi: 10.3892/mco.2017.1413. Epub 2017 Sep 19. Mol Clin Oncol. 2017. PMID: 29181163 Free PMC article.
155 results